Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01656434Phase 3Terminated
Phase 3, randomised, open-label trial of nomegestrol and estradiol in pregnancy (2 arms), sponsored by Organon & Co. Primary endpoint: Number of In-Treatment Pregnancies Per 100 Woman Years of Exposure (Pearl Index) at 1 year. Started Nov 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01656434.